Divi's Laboratories Limited (DIVISLAB) — Announcement Announcement
📢 Key Event
Divi's Laboratories opens special window for physical share transfer and dematerialisation per SEBI directive.
💡 Investor Takeaway
Shareholders holding physical shares now have a designated window to convert them to electronic form, streamlining settlement and reducing administrative burden.
Divi's Laboratories Limited published newspaper advertisements on March 14, 2026, announcing the opening of a special window for transfer and dematerialisation of physical shares, as mandated by SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026. The notices appeared in Financial Express (English) and Andhra Prabha (Telugu, Hyderabad edition), with copies also available on the company's website.
📄 View Original Announcement (PDF)
About Divi's Laboratories Limited (DIVISLAB)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹1,79,470.03 Cr
P/E: 72.4
ROE: 16.6%
ROCE: 22.1%
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.